Neomorph has entered into a collaboration and licensing agreement with global healthcare company Novo Nordisk to discover, develop and commercialize molecular glue degraders. Neomorph, a biotechnology company solving critical problems...

View the Online Magazine

Launches

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

ACG showcases concept of next generation capsule filling machine – AF330 at CPHI and PMEC 2023

ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is set to unveil its next generation capsule filling...

ACG Engineering launches the SMARTCOATER X•ONE Series

ACG Engineering, a division of ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is delighted to launch...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Outcome Management: The cure for pharma’s toughest trials – by Johannes Müller, co-founder and CEO of Workpath

The pharmaceutical sector is currently grappling with significant challenges that are impacting its operations and long-term viability.  Rising cost pressures due to inflation and...

Approvals

Manufacturiung

Finance

Research & Development
Latest

Neomorph and Novo Nordisk to discover novel molecular glue degraders

Neomorph has entered into a collaboration and licensing agreement with global healthcare company Novo Nordisk to discover, develop and commercialize molecular glue degraders. Neomorph, a...

AbbVie and Tentarix to develop conditionally-active, multi-specific biologics for oncology and immunology

AbbVie and Tentarix Biotherapeutics have announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology....

Bavarian Nordic’s chikungunya vaccine candidate granted accelerated assessment by European Medicines Agency

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted accelerated assessment for the upcoming Marketing Authorisation...

U.S. FDA Fast Track designation granted for Diamyd

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Diamyd Medical's Diamyd®(rhGAD65/alum), which is being investigated to improve glycemic control...

VantAI to collaborate with Bristol Myers Squibb to accelerate molecular glue drug discovery through AI

VantAI, a company focused on generative AI-enabled drug discovery, and Bristol Myers Squibb have entered into a strategic collaboration to discover new molecular glues...

Appointments